相关实验视频
Updated: Jun 23, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
对精神病和抗精神病干预的新见解:从控制症状到改善结果
Adonis Sfera1,2,3, Hassan Imran1,2,3, Dan O Sfera1,2,3
1Patton State Hospital, 3102 Highland Ave., Patton, CA 92369, USA.
International journal of molecular sciences
|June 19, 2024
概括
精神分裂症可能源于过早的细胞衰老,由环境毒素激活烯碳化合物受体驱动. 新型老年疗法有可能改善这种精神疾病的长期结果.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 精神病学是一个精神病学.
背景情况:
- 多巴胺假设已经指导了精神分裂症的治疗70年,产生症状缓解,但有限的结果改善.
- 精神分裂症越来越多地与可量化的病理有关,如早衰,大脑体积丧失和大脑振荡的改变.
- 环境毒素和肠道微生物组失生症与精神分裂症的发病有关.
研究的目的:
- 审查早期细胞和神经元衰老在精神分裂症中的作用.
- 探索针对衰老的新型治疗策略,以改善精神分裂症的长期结果.
主要方法:
- 这篇叙事综述综合了关于精神分裂症细胞衰老的现有研究.
- 它检查了阿里碳化合物受体激活导致衰老的拟议机制.
- 基于当前的文献讨论了潜在的治疗干预措施.
主要成果:
- 过早的细胞和神经元衰老是精神分裂症的潜在标志,可能是由环境因素引发的.
- 精神分裂症的早期大脑衰老导致线粒体功能障碍,灰质损失和大脑活动的改变.
- 目前的治疗方法提供有限的长期益处,需要新的方法.
结论:
- 异常的aryl碳化合物受体激活可能通过过早衰老驱动精神分裂症.
- 用老年疗法,脂质替代或线粒体疗法准衰老,为改善精神分裂症结果提供了有希望的途径.
- 对这些新策略的进一步研究是有必要的.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
14.9K
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
234
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
234
01:26Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:24Mania and Antimanic Drugs: Overview
168
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
168
01:26Positive Symptoms Schizophrenia: Hallucinations and Delusions
53
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
53
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
569
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
569